Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nova Eye Medical (AU:EYE)
ASX:EYE
Holding AU:EYE?
Track your performance easily
EYE Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.12 - AU$0.32
Previous CloseAU$0.15
Volume36.70K
Average Volume (3M)218.64K
Market Cap
AU$33.22M
Enterprise ValueAU$27.16M
Total Cash (Recent Filing)AU$8.00M
Total Debt (Recent Filing)AU$1.94M
Price to Earnings (P/E)―
Beta-0.17
Next Earnings
Feb 20, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 21, 2020Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares OutstandingN/A
10 Day Avg. Volume200,788
30 Day Avg. Volume218,644
Standard Deviation0.22
R-Squared0.14
Alpha0.00377
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)2.21
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nova Eye Medical News
PremiumCompany Announcements
Nova Eye Medical Announces Director’s Securities Change
PremiumCompany Announcements
Nova Eye Medical Issues New Performance Rights
PremiumCompany Announcements
Nova Eye Medical Updates on Director’s Securities Changes
PremiumCompany Announcements
Nova Eye Medical Discusses Future Expectations and RisksPremiumCompany Announcements
Nova Eye Medical Sees Strong Sales Growth in Key Markets
PremiumCompany Announcements
Nova Eye Medical Sets Annual Meeting Date
PremiumCompany Announcements
Nova Eye Medical Schedules AGM and Director ElectionsPremiumCompany Announcements
Nova Eye Medical Affirms Corporate Governance ComplianceOptions Prices
Currently, No data available
---
Ownership Overview
EYE FAQ
What was Nova Eye Medical’s price range in the past 12 months?
Nova Eye Medical lowest share price was AU$0.12 and its highest was AU$0.32 in the past 12 months.
What is Nova Eye Medical’s market cap?
Currently, no data Available
When is Nova Eye Medical’s upcoming earnings report date?
Nova Eye Medical’s upcoming earnings report date is Feb 20, 2025 which is in 59 days.
How were Nova Eye Medical’s earnings last quarter?
Nova Eye Medical released its earnings results on Aug 25, 2024. The company reported -AU$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.014.
Is Nova Eye Medical overvalued?
According to Wall Street analysts Nova Eye Medical’s price is currently Overvalued.
Does Nova Eye Medical pay dividends?
Nova Eye Medical pays a Notavailable dividend of AU$0.135 which represents an annual dividend yield of N/A. See more information on Nova Eye Medical dividends here
What is Nova Eye Medical’s EPS estimate?
Nova Eye Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nova Eye Medical have?
Nova Eye Medical has 229,072,770 shares outstanding.
What happened to Nova Eye Medical’s price movement after its last earnings report?
Nova Eye Medical reported an EPS of -AU$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nova Eye Medical?
Currently, no hedge funds are holding shares in AU:EYE
---
Nova Eye Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-38.77%
Trailing 12-Months
Asset Growth
-1.24%
Trailing 12-Months
Company Description
Nova Eye Medical
Ellex Medical Lasers Ltd. engages in design and manufacture of ophthalmic laser and ultrasound systems used by ophthalmologists to diagnose and treat eye diseases. It operates through the following segments: Faster Growing (iTrack), Emerging (2RT), and Core Ophthalmic Mark (Lasers and Ultrasounds). The iTrack segment offers catheter device that dilates the ocular structures compromised by glaucoma. The 2RT segment includes patent-protected with significant lead on competition and a per-use recurring fee business model. The Lasers and Ultrasounds segment represents testimony to the strength of the Ellex brand and was driven by growth in sales of the high-margin Ellex Tango and Ellex Tango Reflex glaucoma lasers. The company was founded by Giuseppe Canala and Victor Previn in 1985 and is headquartered in Adelaide, Australia.
---
Technical Analysis
---